These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9714028)

  • 1. Pain perception following subcutaneous injections of citrate-buffered and phosphate-buffered epoetin alpha.
    Yu AW; Leung CB; Li PK; Lui SF; Lai KN
    Int J Artif Organs; 1998 Jun; 21(6):341-3. PubMed ID: 9714028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta.
    Veys N; Dhondt A; Lameire N
    Clin Nephrol; 1998 Jan; 49(1):41-4. PubMed ID: 9491285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin.
    Veys N; Vanholder R; Lameire N
    Am J Nephrol; 1992; 12(1-2):68-72. PubMed ID: 1415368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients.
    Schmitt CP; Nau B; Brummer C; Rosenkranz J; Schaefer F
    Nephrol Dial Transplant; 2006 Dec; 21(12):3520-4. PubMed ID: 16935904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection.
    Frenken LA; van Lier HJ; Jordans JG; Leunissen KM; van Leusen R; Verstappen VM; Koene RA
    Am J Kidney Dis; 1993 Oct; 22(4):553-6. PubMed ID: 8213795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain perception after subcutaneous injections of media containing different buffers.
    Laursen T; Hansen B; Fisker S
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):218-21. PubMed ID: 16445598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial comparing local pain after subcutaneous injection of epoetin-beta versus darbepoetin-alpha in healthy volunteers.
    Berthoux F; Ryckelynck JP; Rouanet S; Gelu-Mantoulet S; Montestruc F; Mouchel P; Choukroun G;
    Clin Nephrol; 2008 Jul; 70(1):33-40. PubMed ID: 18793546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain after subcutaneous injection of recombinant human erythropoietin: does Emla cream help?
    Morris KP; Hughes C; Hardy SP; Matthews JN; Coulthard MG
    Nephrol Dial Transplant; 1994; 9(9):1299-301. PubMed ID: 7816294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate pain sensation is less with subcutaneous epoietin-beta compared to subcutaneous darbepoietin-alpha.
    Ter Wee PM; de Koter Y; van der Veer O; van Vliet MH
    Clin Nephrol; 2009 Sep; 72(3):177-80. PubMed ID: 19761721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of epogen in hemodialysis patients.
    St Peter WL; Lewis MJ; Macres MG
    Am J Kidney Dis; 1998 Sep; 32(3):470-4. PubMed ID: 9740164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change of EPO treatment from subcutaneous epoetin to intravenous epoetin or darbepoetin alpha].
    Molina M; García Hernández MA; Navarro MJ; De Gracia MC; Ortuño T
    Nefrologia; 2004; 24(6):564-71. PubMed ID: 15683029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease.
    Roger SD; Suranyi MG; Walker RG; Disney A; Isbel NM; Kairaitis L; Pollock CA; Brown FG; Chow J; Truman MI; Ulyate KA;
    Curr Med Res Opin; 2008 Aug; 24(8):2181-7. PubMed ID: 18565240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa.
    Frenken LA; van Lier HJ; Koene RA
    Nephrol Dial Transplant; 1994; 9(9):1295-8. PubMed ID: 7816293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous erythropoietin alpha (Eprex) is more painful than erythropoietin beta (Recormon).
    Cumming MN; Sharkey IM; Sharp J; Plant ND; Coulthard MG
    Nephrol Dial Transplant; 1998 Mar; 13(3):817. PubMed ID: 9550687
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study.
    Granolleras C; Leskopf W; Shaldon S; Fourcade J
    Clin Nephrol; 1991 Dec; 36(6):294-8. PubMed ID: 1769141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid growth hormone: preservatives and buffers.
    Kappelgaard AM; Bojesen A; Skydsgaard K; Sjögren I; Laursen T
    Horm Res; 2004; 62 Suppl 3():98-103. PubMed ID: 15539807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subcutaneous administration route of epoetin: advantages, pain at the injection site and patient acceptance.
    Vey SN; Ringoir S
    Int J Artif Organs; 1993 Jan; 16(1):1-3. PubMed ID: 8458665
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.
    Togawa A; Tanaka T; Nagashima S; Keta H; Kobayashi Y; Nishikawa Y; Yanai M; Tanaka H
    Br J Clin Pharmacol; 2004 Sep; 58(3):269-76. PubMed ID: 15327586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoetin theta: efficacy and safety of subcutaneous administration in anemic pre-dialysis patients in the maintenance phase in comparison to epoetin beta.
    Gertz B; Kes P; Essaian A; Bias P; Buchner A; Zellner D
    Curr Med Res Opin; 2012 Jul; 28(7):1101-10. PubMed ID: 22533679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.